Literature DB >> 14624812

Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder.

Davide Viggiano1, Daniela Vallone, Lucia A Ruocco, Adolfo G Sadile.   

Abstract

Clinical and experimental evidence suggest an involvement of dopamine systems, mainly the mesocorticolimbic one (MCL), in Attention-Deficit Hyperactivity Disorder (ADHD). However, it remains to be ascertained whether the systems are hyper- or hypo-functioning, for the implications of the functional state. Indeed, differential functional states of the MCL branches are suggested to be the neural substrate of different ADHD variants. This review covers published and unpublished data from the Naples-High Excitability (NHE) rat, an animal model of ADHD, featuring its main aspects, with no hypertension. Therefore, a multiple approach based on morphological studies of dopamine, norepinephrine, glutamate, acetylcholine and GABA systems, synaptic (Calcium/Calmodulin kinase II) and extrasynaptic (chondroitin sulphates) environments, and molecular biology and pharmacological studies on the dopamine system has been carried out. Morphological findings suggest dopamine neurons in the Ventral Tegmental Area (VTA) to be hypertrophic in NHE rats. The mesostriatal and mesolimbic dopamine branches appear to be normal in basal conditions. However, the striatal interface is probably defective following activation. Conversely, the prefrontal cortex, which represents the second main target of VTA dopamine neurons, has many alterations at the basal level. Therefore, the emerging picture is the association of a hyperinnervating and hyperfunctioning mesocortical branch of the dopamine system. Thus, the evidence gathered so far might improve our understanding of the neural substrates of neuropsychiatric disorders such as ADHD, schizophrenia and drug addiction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624812     DOI: 10.1016/j.neubiorev.2003.08.011

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  17 in total

1.  Molecular basis for catecholaminergic neuron diversity.

Authors:  Jan Grimm; Anne Mueller; Franz Hefti; Arnon Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

2.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

Review 3.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

4.  Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background.

Authors:  Brian O'Neill; Howard H Gu
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

Review 5.  Animal models of RLS phenotypes.

Authors:  Richard P Allen; Nathan C Donelson; Byron C Jones; Yuqing Li; Mauro Manconi; David B Rye; Subhabrata Sanyal; Juliane Winkelmann
Journal:  Sleep Med       Date:  2016-09-02       Impact factor: 3.492

Review 6.  Pharmacological models of ADHD.

Authors:  R M Kostrzewa; J P Kostrzewa; R A Kostrzewa; P Nowak; R Brus
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

7.  Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.

Authors:  Elyssa B Margolis; Jennifer M Mitchell; Junko Ishikawa; Gregory O Hjelmstad; Howard L Fields
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

8.  Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.

Authors:  Pablo Pandolfo; Leandro F Vendruscolo; Regina Sordi; Reinaldo N Takahashi
Journal:  Psychopharmacology (Berl)       Date:  2009-05-01       Impact factor: 4.530

Review 9.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

10.  Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex.

Authors:  Elyssa B Margolis; Hagar Lock; Vladimir I Chefer; Toni S Shippenberg; Gregory O Hjelmstad; Howard L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.